³ÐÃIJ·s·|ij Drug Discovery Innovation Summit |
·s¦¡¯kµhªvÀø Targeting Pain with Novel Therapeutics
·s¦¡ªü¯÷¨uÀq¯gªvÀø Targeting Alzheimer¡¦s with Novel Therapeutics
HTSªº²ÓM・²Õ´¤ÀªR Cell and Tissue-Based Assays for HTS
»sÃĵ¦²¤¨t¦C Pharmaceutical Strategy Series |
¦³®ÄªººÞ²z»P¥ø¹ººÞ²z¾ã¦X Integrating Effective Alliance Management and Project Management
Ãľ¯¦w¥þ©Ê·|ij Drug Safety Summit
ÃÙ§U¼t°Ó¡Gthe Drug Safety Executive Council
|
¤ßŦ¬r©Ê»PÃĪ«¦w¥þ©Ê Cardiotoxicity and Drug Safety
¨xŦ¬r©Ê»PÃĪ«¦w¥þ©Ê Hepatotoxicity and Drug Safety
ÃĪ«¦w¥þ©Ê¹ï·s°Êª«´ú¸Õ¬¡Å骺¼vÅTÂX¤j The Expanding Impact of New Animal Models in Drug Safety
|
¨Æ«e·|ijµu´Á½Òµ{
6¤ë8¤é¡]¤@¡^
|
SC1: ¤ßŦªº¦w¥þ©Ê: §ïµ½«eÁ{§É¹w´ú,¥H¹F¨ìÁ{§Éµ²ªG´£¤É¬°¥Øªº Cardiac Safety: Improving pre-clinical predictions to better clinical outcomes
SC2: high contents screening¡]HCS¡^ - ¬°¹F¨ì³ÐÃĨ³³t¤Æ¤§¾ã¦X¿ìªk HighContent Screening-Integrated Solutions for Accelerated Drug Discovery
SC3: ªü¯÷¨uÀq¯gªº´ú¸Õ³]p¤Wªº¯Ê³´°£¿ù Avoiding Pitfalls in Alzheimer's Clinical Trial Design
SC4: ¶i¦æ¦w¥þªºscreeningÂ÷¤l¨î±s¤ÀªR Ion Channel Assays for Safety Screening
SC5: «P¶i«eÁ{§ÉR&Dµ{§Ç¤W±Ä¥Î·s¿³§Þ³Nªº¹ïµ¦¿ìªk Collaborating to Accelerate the Adoption of Novel Technologies in the Preclinical R&D Process
SC6: ¯kµhªvÀø¥Î°Êª«¬¡Åé Animal Models for Pain-Improving Translation to the Clinic
|